1,095 results on '"Hwang, E. Shelley"'
Search Results
2. Trajectory of Subsequent Breast Cancer Diagnoses in a Diverse Patient Cohort with Breast Atypia
3. Utility of Axillary Staging in Older Patients with HER2-Positive Breast Cancer
4. Survival among patients with untreated metastatic breast cancer: “What if I do nothing?”
5. ASO Visual Abstract: Utility of Axillary Staging in Older Patients with HER2-Positive Breast Cancer
6. ASO Author Reflections: Trajectory of Subsequent Breast Cancer After Breast Atypia Diagnosis Suggests Need for Vigilant Follow-up
7. A convolutional neural network STIFMap reveals associations between stromal stiffness and EMT in breast cancer.
8. ASO Visual Abstract: Trajectory of Subsequent Breast Cancer Diagnoses in a Diverse Patient Cohort with Breast Atypia
9. Identifying Good Candidates for Active Surveillance of Ductal Carcinoma in Situ: Insights from a Large Neoadjuvant Endocrine Therapy Cohort
10. Contralateral Prophylactic Mastectomy Decision-Making: The Partners’ Perspective
11. Neoadjuvant Chemotherapy and Endocrine Therapy for Older Patients with Estrogen Receptor Positive Breast Cancer: Comparison of Approaches
12. Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors
13. Immunosuppressive glycoproteins associate with breast tumor fibrosis and aggression
14. Axillary nodal disease burden is not associated with an elevated 21-gene recurrence score in post-menopausal women presenting with a clinically negative axilla
15. The Landmark Series—Ductal Carcinoma in Situ: The Evolution of Treatment
16. DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCIS
17. Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort.
18. ASO Visual Abstract: Contralateral Prophylactic Mastectomy Decision Making—The Partners’ Perspective
19. Anatomy Versus Biology: What Guides Chemotherapy Decisions in Older Patients With Breast Cancer?
20. Survival Benefit of Chemotherapy According to 21-Gene Recurrence Score in Young Women with Breast Cancer
21. De-escalation in DCIS Care
22. Mechanosensitive hormone signaling promotes mammary progenitor expansion and breast cancer risk
23. Transforming the Future of Surgeon-Scientists
24. Implications of missing data on reported breast cancer mortality
25. Learning to distinguish progressive and non-progressive ductal carcinoma in situ
26. Matrix compliance permits NF-κB activation to drive therapy resistance in breast cancer
27. Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression
28. TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer
29. Self-supervised deep learning for highly efficient spatial immunophenotyping
30. Archival single-cell genomics reveals persistent subclones during DCIS progression
31. ASO Visual Abstract: Neoadjuvant Chemotherapy and Endocrine Therapy for Older Patients with Estrogen Receptor Positive Breast Cancer—Comparison of Approaches
32. Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217
33. The Influence of Body Mass Index on the Histopathology and Outcomes of Patients Diagnosed with Atypical Breast Lesions
34. Pain Control in Breast Surgery: Survey of Current Practice and Recommendations for Optimizing Management—American Society of Breast Surgeons Opioid/Pain Control Workgroup
35. Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance).
36. The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution.
37. Derivation of a nuclear heterogeneity image index to grade DCIS
38. DCIS AI-TIL: Ductal Carcinoma In Situ Tumour Infiltrating Lymphocyte Scoring Using Artificial Intelligence
39. Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ.
40. Synchronous Detection of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow Predicts Adverse Outcome in Early Breast Cancer
41. The role of tumor phenotype in the surgical treatment of early-stage breast cancer
42. Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer
43. Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts
44. Digital Health Platforms for Breast Cancer Care: A Scoping Review
45. Spatial interplay of tissue hypoxia and T-cell regulation in ductal carcinoma in situ
46. Development of a new adapted QuinteT Recruitment Intervention (QRI-Two) for rapid application to RCTs underway with enrolment shortfalls—to identify previously hidden barriers and improve recruitment
47. A web-based personalized decision support tool for patients diagnosed with ductal carcinoma in situ: development, content evaluation, and usability testing
48. ASO Visual Abstract: Survival Benefit of Chemotherapy According to 21-Gene Recurrence Score in Young Women with Breast Cancer
49. Deep learning analysis of breast MRIs for prediction of occult invasive disease in ductal carcinoma in situ
50. Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.